// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-08-13\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often ",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "HANCESTRO DOID MANDATORY ANY ROW III SILAC README INITIATIVE developmental stage WARRANTY file your MS MHC AS RECOMMEND ENVO PRM REQUIRED LIMITED OPTIONAL ZFA biosample accession number proteomics data acquisition method age SP VCF BMC COULD OF pooled sample organism PATO LC THAT fractionation method QY ISA EXPRESS instrument IDF sample NOT SRM JA CID MIAME WILL SH source name cleavage agent details TMT individual RAW PURPOSE USE disease stage NOTE XML RECOMMENDED TO alkylation reagent EW PARTICULAR RFC BRENDA DISCLAIMS MAJOR WARRANTIES MAY ID COLUMN CN biological replicate PMID TA sex EBI NT TIP dissociation method depletion PRIDE:0000659 fraction identifier replicate RIGHTS URL INCLUDING HCD PROTEOMICS MOD UBERON VK organism part mass disease PSI characteristics CL SDRF CT INFRINGE MONDO NCBI II CELL HEREIN cell type PP CPTAC MC INFORMATION technical replicate BE MERCHANTABILITY PMCID IAA MS:1001251 SWATH DIA CS PS data file reduction reagent MINOR PRIDE HUPO HF CF STANDARDS SHOULD IS FITNESS LI TAB DJ MUST PO EFO REQUIRES SN NCE label URI source name_ and _assay name CLO IMPORTANT MT ancestry category collision energy exclamation XL BUT DDA THE PATCH AC FOR BTO DTT MAGE SHALL IMPLIED CV EM ... HTML ALL spiked compound PEPTIDESEQ OR FDR PTM"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-08-13\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often ",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "HANCESTRO DOID MANDATORY ANY ROW III SILAC README INITIATIVE WARRANTY MS MHC AS RECOMMEND ENVO PRM REQUIRED LIMITED OPTIONAL ZFA biosample accession number proteomics data acquisition method age SP VCF BMC COULD OF pooled sample organism PATO LC THAT fractionation method QY ISA EXPRESS instrument IDF NOT SRM JA CID MIAME WILL SH cleavage agent details TMT individual RAW PURPOSE USE disease stage RECOMMENDED TO alkylation reagent EW PARTICULAR RFC BRENDA DISCLAIMS MAJOR WARRANTIES MAY COLUMN CN biological replicate PMID TA sex EBI NT dissociation method depletion PRIDE:0000659 fraction identifier RIGHTS URL INCLUDING HCD PROTEOMICS MOD UBERON VK organism part mass disease PSI CL SDRF CT INFRINGE MONDO NCBI II CELL HEREIN cell type PP CPTAC MC INFORMATION technical replicate BE MERCHANTABILITY PMCID IAA MS:1001251 SWATH DIA CS PS data file reduction reagent MINOR PRIDE HUPO HF CF STANDARDS SHOULD IS FITNESS LI TAB DJ MUST PO EFO REQUIRES SN NCE label URI CLO MT ancestry category collision energy XL BUT DDA THE PATCH AC FOR BTO DTT MAGE SHALL IMPLIED CV EM ... HTML ALL spiked compound PEPTIDESEQ OR FDR PTM"
  },
  {
    "title": "Sample Metadata Conventions",
    "content": "Sample Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These conventions apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata conventions define standardized formats for common properties that apply across all organism types. This convention covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Convention.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSk",
    "url": "./conventions/sample-metadata.html",
    "section": "Sample Metadata Convention",
    "keywords": "HANCESTRO DOID developmental stage PDX age UBERON:0002048 PATO:0000383 CL:0000236 organism PATO xenograft UBERON:0002097 PATO:0000461 CL:0000066 CL:0000625 MONDO:0005105 CL:0000540 MONDO:0005180 NSG compound MONDO:0005301 source name UBERON:0000178 individual UBERON:0001088 CL:0000232 NOTE COVID UBERON:0002107 MONDO:0005138 CL:0000624 enrichment process UBERON:0000955 CL:0000815 MAY ID biological replicate CL:0000623 sex UBERON:0002113 TIP CL:0000084 depletion lib UBERON:0001977 URL MONDO:0004989 UBERON:0001969 UBERON:0000310 DSS UBERON organism part CSF disease CL SDRF CL:0000235 CL:0000451 MONDO:0004946 MONDO CL:0000233 NCBI cell type UBERON:0000948 MONDO:0004975 CL:0000057 SHOULD PO MUST MONDO:0005575 CL:0000788 EFO UBERON:0001155 UBERON:0001359 CML IMPORTANT PATO:0000384 ancestry category CL:0000813 disease model NK PATO:0001340 CL:0000576 exclamation MONDO:0008383 MONDO:0005148 CL:0000182 CL:0000898 CL:0000913 CL:0000787 ALL APP synthetic peptide PTM MONDO:0100096"
  },
  {
    "title": "Sample Metadata Conventions",
    "content": "Sample Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These conventions apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata conventions define standardized formats for common properties that apply across all organism types. This convention covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Convention.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSk",
    "url": "./conventions/sample-metadata.html#sample-metadata-conventions",
    "section": "Sample Metadata Convention",
    "keywords": "HANCESTRO DOID developmental stage PDX age UBERON:0002048 PATO:0000383 CL:0000236 organism PATO xenograft UBERON:0002097 PATO:0000461 CL:0000066 CL:0000625 MONDO:0005105 CL:0000540 MONDO:0005180 NSG compound MONDO:0005301 source name UBERON:0000178 individual UBERON:0001088 CL:0000232 COVID UBERON:0002107 MONDO:0005138 CL:0000624 enrichment process UBERON:0000955 CL:0000815 MAY ID biological replicate CL:0000623 sex UBERON:0002113 CL:0000084 depletion UBERON:0001977 URL MONDO:0004989 UBERON:0001969 UBERON:0000310 DSS UBERON organism part CSF disease CL SDRF CL:0000235 CL:0000451 MONDO:0004946 MONDO CL:0000233 NCBI cell type UBERON:0000948 MONDO:0004975 CL:0000057 SHOULD PO MUST MONDO:0005575 CL:0000788 EFO UBERON:0001155 UBERON:0001359 CML PATO:0000384 ancestry category CL:0000813 disease model NK PATO:0001340 CL:0000576 MONDO:0008383 MONDO:0005148 CL:0000182 CL:0000898 CL:0000913 CL:0000787 ALL APP synthetic peptide PTM MONDO:0100096"
  },
  {
    "title": "Human Sample Metadata Convention",
    "content": "Human Sample Metadata Convention\n\nStatus of this Convention\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These conventions apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This convention defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata conventions (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Conventions.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g",
    "url": "./conventions/human-metadata.html",
    "section": "Human Metadata Convention",
    "keywords": "HANCESTRO NCIT:C14167 MONDO:0011122 III NCIT:C18058 NCIT:C15262 weight MONDO:0002050 NCIT:C18206 NCIT:C28054 NCIT PR age NCIT:C4870 alcohol consumption NCIT:C27971 dose CHEBI:28748 organism treatment response NCIT:C65107 ACE NCIT:C81328 PREFERRED NCIT:C18213 NCIT:C27966 NCIT:C65106 breast cancer subtype NCIT:C28077 NCIT:C15445 ethnicity HIPAA compound individual HANCESTRO:0006 disease stage NOTE NCIT:C15632 NCIT:C16358 NCIT:C14169 MONDO:0005044 NCIT:C27970 ID treatment status NCIT:C14174 sex NCIT:C53555 MONDO:0005300 PD NCIT:C71732 NCIT:C53556 GDPR NCIT:C15329 CHEBI:27899 organism part AJCC CHEBI:41774 disease NCIT:C15313 SDRF MONDO II NCIT:C28076 UO NCIT:C65108 secondary condition NCI NCIT:C53554 MONDO:0004979 CHEBI:6801 HANCESTRO:0005 NCIT:C53553 smoking status time post treatment TNM body mass index menopausal status gestational age EFO pregnancy status treatment MONDO:0004995 Ann Arbor stage medication history pre-existing condition TNM staging NCIT:C28079 IV IMPORTANT ancestry category NCIT:C68804 NCIT:C81327 prior treatment HANCESTRO:0009 height exclamation MONDO:0005148 ER NCIT:C62723 HANCESTRO:0010 BMI tumor grade NCIT:C14168 diet NCIT:C28078 Dukes stage sampling time point"
  },
  {
    "title": "Human Sample Metadata Convention",
    "content": "Human Sample Metadata Convention\n\nStatus of this Convention\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These conventions apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This convention defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata conventions (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Conventions.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g",
    "url": "./conventions/human-metadata.html#human-sample-metadata-convention",
    "section": "Human Metadata Convention",
    "keywords": "HANCESTRO NCIT:C14167 MONDO:0011122 III NCIT:C18058 NCIT:C15262 weight MONDO:0002050 NCIT:C18206 NCIT:C28054 NCIT PR age NCIT:C4870 alcohol consumption NCIT:C27971 dose CHEBI:28748 organism treatment response NCIT:C65107 ACE NCIT:C81328 PREFERRED NCIT:C18213 NCIT:C27966 NCIT:C65106 breast cancer subtype NCIT:C28077 NCIT:C15445 ethnicity HIPAA compound individual HANCESTRO:0006 disease stage NCIT:C15632 NCIT:C16358 NCIT:C14169 MONDO:0005044 NCIT:C27970 ID treatment status NCIT:C14174 sex NCIT:C53555 MONDO:0005300 PD NCIT:C71732 NCIT:C53556 GDPR NCIT:C15329 CHEBI:27899 organism part AJCC CHEBI:41774 disease NCIT:C15313 SDRF MONDO II NCIT:C28076 UO NCIT:C65108 secondary condition NCI NCIT:C53554 MONDO:0004979 CHEBI:6801 HANCESTRO:0005 NCIT:C53553 smoking status time post treatment TNM body mass index menopausal status gestational age EFO pregnancy status treatment MONDO:0004995 Ann Arbor stage medication history pre-existing condition TNM staging NCIT:C28079 IV ancestry category NCIT:C68804 NCIT:C81327 prior treatment HANCESTRO:0009 height MONDO:0005148 ER NCIT:C62723 HANCESTRO:0010 BMI tumor grade NCIT:C14168 diet NCIT:C28078 Dukes stage sampling time point"
  },
  {
    "title": "Data File Metadata Conventions",
    "content": "Data File Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These conventions define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata conventions define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This convention covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata conventions (organism, age, sex, disease), see Sample Metadata Conventions.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\ns",
    "url": "./conventions/data-file-metadata.html",
    "section": "Data File Metadata Convention",
    "keywords": "MS1 scan range label MS:1001313 PSI cleavage agent details TMT URI RAW MM SILAC IMPORTANT SDRF MT MS:1001309 LTQ NOTE MS RECOMMENDED MRM ELISA MGF file uri PRM PP REQUIRED exclamation TOF RPPA technical replicate XL UNIMOD:1 modification parameters UNIMOD:35 ID UNIMOD:737 MS:1001303 DDA MSD PRIDE:0000663 MS:1001251 FTP AC proteomics data acquisition method DIA CS precursor mass tolerance TA data file proteomexchange accession number NT TIP PRIDE fraction UNIMOD:21 HF fraction identifier CF UNIMOD UNIMOD:4 MS:1001917 KR MS2 analyzer type scan window upper limit SHOULD URL fragment mass tolerance MUST instrument sample scan window lower limit MOD SRM SCIEX ST MS:1001306 TS"
  },
  {
    "title": "Data File Metadata Conventions",
    "content": "Data File Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These conventions define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata conventions define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This convention covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata conventions (organism, age, sex, disease), see Sample Metadata Conventions.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\ns",
    "url": "./conventions/data-file-metadata.html#data-file-metadata-conventions",
    "section": "Data File Metadata Convention",
    "keywords": "MS1 scan range label MS:1001313 PSI cleavage agent details TMT URI RAW MM SILAC SDRF MT MS:1001309 LTQ MS RECOMMENDED MRM ELISA MGF file uri PRM PP REQUIRED TOF RPPA technical replicate XL UNIMOD:1 modification parameters UNIMOD:35 ID UNIMOD:737 MS:1001303 DDA MSD PRIDE:0000663 MS:1001251 FTP AC proteomics data acquisition method DIA CS precursor mass tolerance TA data file proteomexchange accession number NT PRIDE UNIMOD:21 HF fraction identifier CF UNIMOD UNIMOD:4 MS:1001917 KR MS2 analyzer type scan window upper limit SHOULD URL fragment mass tolerance MUST instrument scan window lower limit MOD SRM SCIEX ST MS:1001306 TS"
  }
];
